The largest database of trusted experimental protocols

Stata ic version 14

Manufactured by StataCorp
Sourced in United States

Stata/IC version 14 is a statistical software package developed by StataCorp. It provides a comprehensive set of tools for data analysis, management, and graphics. Stata/IC version 14 is designed to handle a wide range of data types and can be used for a variety of statistical techniques, including regression analysis, time series analysis, and survey data analysis.

Automatically generated - may contain errors

108 protocols using stata ic version 14

1

Antibiotic Knowledge and Demographic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were analyzed using STATA/IC (version 14.2). Descriptive measures were presented in percentages. Differences in distribution between groups were compared using logistic regression with an estimate of 95% confidence intervals (CIs). For all tests, p-values of 0.05 or less were used to determine the level of significant difference. Multivariate analysis was employed to assess the relationship between levels of knowledge about antibiotics and receiving information and demographic data such as gender, age, area of residence, education level and wealth status as shown in Table 2. The variables were selected by reviewing literatures and analysing the significant bivariate association. We used the cut off point for the outcome variable of level of knowledge as lower and equal to and higher than three correct answers (>50% of total questions).
+ Open protocol
+ Expand
2

Diabetes Impact on In-Hospital Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, we compared the patients` data across diabetes status. The normality assumption for continuous variables was checked graphically by a histogram plot and the Shapiro-Wilk statistical test. Because of the non-normal distribution of the study variables, they were reported as the median and interquartile range (IQR) and were compared using Mann-Whitney U tests. In order to compare categorical variables, Chi-square tests were used, and the data were reported as numbers and percentages. We used univariate logistic regression analysis to evaluate the association between diabetes and in-hospital outcomes. Then, we used the change-in-estimate (CIE) criterion with a cut-off of more than 10% to detect the probable confounders of this association. Multiple logistic regression analysis was used to adjust for confounders identified by the CIE criterion. Both crude and adjusted ORs were reported for the association between diabetes and in-hospital outcomes with a 95% confidence interval (CI). Data analyses were performed by the statistical package STATA/IC version 14.2 (Stata Corp LP College Station, TX, USA).
+ Open protocol
+ Expand
3

Determinants of HPV Vaccine Intention

Check if the same lab product or an alternative is used in the 5 most similar protocols
We summarized continuous variables using means with standard deviations and categorical variables with percentages and 95% Wald Confidence Intervals (CI). To test the statistical significance of the difference between the intention to vaccinate of each categorical variable, the χ2 test was applied. T-test was used when testing continuous variables. Backward stepwise logistic regression analysis was used to study the effect of independent variables on the intention to the HPV vaccine. A p-value <0.2 was required for retention of each variable in the final model. Multicollinearity of independent variables was checked by the variance inflation factor (VIF) statistic. Results are presented as crude (ORc) or adjusted odds ratio (aOR) and 95% confidence intervals (CI). The Area Under the Curve (AUC) and Hosmer-Lemeshow goodness of fit tests were considered as discrimination and calibration parameters for the model. All statistical analyses were performed using the statistical software Stata IC, version 14.2 (Stata Corp., College Station, TX, USA). Due to the complex sampling design, we used the svyset command to account for sample stratification and weighting to provide unbiased estimates of the population parameters. Statistical significance was defined as a two-sided p-value <0.05 for all tests.
+ Open protocol
+ Expand
4

Predictors of Successful Anterior Cervical Stabilization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Univariate and bivariate descriptive and inferential statistical methods were used to
compare demographic, injury and surgical specific metrics between the 2 groups. The
Student t test was used to analyze continuous, noncategorical data, and
Fisher’s exact test for categorical data. The sample size was determined to be adequate
for the number of predictive variables used in the multivariate models using previously
described methods.26 (link) Binary logistic regression analysis was performed for identification of independent
predictors of satisfactory outcomes in patients who underwent standalone anterior cervical
stabilization following spine trauma. Construction of best-fit models was performed with
the dependent variables being NDI of 14 or less, patient satisfaction, VAS-neck of 2 or
less, and VAS-arm of 2 or less. Selection of baseline covariates as independent variables
in the model was based on its P value (<.20) and significance based on
previous published literature. The backward elimination method was selected to assist
model creation. Statistical significance was achieved with a P value
<.05. All statistical analyses were performed using STATA/IC version 14.2 (StataCorp,
College Station, Texas, USA).
+ Open protocol
+ Expand
5

Evaluating End-of-Life Care Resources

Check if the same lab product or an alternative is used in the 5 most similar protocols
We limited all analyses to hospitals with at least 100 study patients to exclude hospitals with limited experience caring for critically ill patients. We compared baseline patient and hospital characteristics using the chi-squared test and t-test for categorical and continuous data, respectively. To test the independent association of admission to a hospital with EOL resources and outcomes, we fit multivariable regression models, including a random intercept for hospitals and all patient and hospital characteristics described above as potential confounders. Linear and logistic mixed-effects regression were used for continuous outcomes and binary outcomes, respectively. All analyses were performed with Stata/IC Version 14.2 (StataCorp LLC, College Station, TX).
+ Open protocol
+ Expand
6

Recurrence Risk Stratification in HCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients stratified by HCC recurrence were compared across a range of the aforementioned variables. Kaplan-Meier survival estimates were generated for 1, 3, and 5-year recurrence by max AFP category and etiology of liver disease. Descriptive statistics were computed as medians and interquartile ranges (IQR). Wilcoxon rank-sum and chi-squared tests were used to compare continuous and categorical data, respectively. For these and subsequent tests, a two-tailed alpha level = 0.05 was used as the threshold for statistical significance unless otherwise stated. All data management and computations were performed using STATA/IC version 14.2.
+ Open protocol
+ Expand
7

Evaluating the Impact of Policy Intervention on Recruitment Progress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sample characteristics were analyzed by group (intervention and
control). The associations between covariates and group were analyzed using
Fisher’s exact test and the Student’s t-tests. Two multiple
logistic regressions were performed to examine the effect of the policy on
recruitment progress for each group. Then, a multiple logistic regression
calculating the difference in pre/post policy change in recruitment progress in
the intervention versus control groups (the difference-in-differences) was
conducted via the following model:

Y = β0 + β1*[Group] +
β2*[Policy Intervention] +
β3*[Difference-in-Differences] +
β4*[Fiscal Year] + β5*[NIMH
Division] + β6*[Total Grant Funds Requested] +
β7*[ClinicalTrials.gov Registered] +
β8*[Planned Trial Sample Size] +
β9*[Grantee Institution Size] + ε

The Difference-in-Differences variable was calculated using Group*Policy
Intervention; therefore, the coefficient for this variable represents only those
grants that were reclassified by the definition change after the policy went
into effect. The model fit was validated using Pearson’s goodness-of-fit
test (p=0.244) and the Hosmer-Lemeshow statistic (p=0.596) which did not
indicate that the predicted probabilities deviate from the observed
probabilities in a way that the binomial distribution does not predict (Minitab
2019). These analyses were conducted using Stata/IC Version 14.2 (StataCorp 2015 ).
+ Open protocol
+ Expand
8

Analyzing UK Primary Care Records

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analysis was performed using patient data from The Health Improvement Network (THIN), an anonymised database of electronic primary care records from UK general practices which use Vision software. THIN includes coded data on patient characteristics, prescriptions, consultations, diagnoses and primary care investigations.
Practices were eligible for inclusion in the study from the latest of the practice acceptable mortality recording (AMR) date, 21 Vision installation date, and study start date (one year prior to the first census date). All analyses were conducted using Stata IC version 14.2.
+ Open protocol
+ Expand
9

Small Sample Statistical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Given the small sample size, normality was not assumed in the continuous data variables. Descriptive statistics were thus computed as medians and interquartile ranges (IQRs), where applicable. The Wilcoxon rank-sum test and Fisher’s exact test were used to compare continuous and categorical variables, respectively, with an alpha level of 0.05 regarded to be statistically significant. Where relevant, missing elements of data were assumed to be missing completely at random, and were excluded from analysis. Data management and computations were performed using STATA/IC version 14.2 (College Station, Texas).
+ Open protocol
+ Expand
10

Survival Analysis of Genomic Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Date of genomic study consent for CGP was the index date for overall survival, and initial clinic visit was the index date for the No CGP group. For both cohorts, this represented the start of the process for identifying investigative treatment options. As the cohorts reflected successive time periods, potential follow-up time was systematically different. All patients had a minimum of 12 months’ follow up and survival analysis was censored at 18 months to reduce discrepancy in time at risk across cohorts. Unadjusted and IPTW adjusted Kaplan-Meier survival curves were used to generate plots and estimate survival probabilities, unadjusted and IPTW adjusted hazard ratios (HRs) were estimated using Cox proportional hazards regression. It was calculated that a HR of 0.65 could be detected with 80% power at a 5% significance level with a sample of 260 and a 65% event rate [30 ]. The proportional hazards assumption was assessed through significance testing of scaled Schoenfeld residuals. Robust variance estimates were used in adjusted analyses to account for the dependency induced through weighting subjects [31 (link)]. Data cleaning was performed in Stata/IC version 14.2 and analysis and graphics performed using R statistical software, version 3.6.3.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!